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Abstract
Background: In women, Chlamydia (C.) trachomatis upper genital tract infection can cause distal tubal
damage and occlusion, increasing the risk of tubal factor subfertility and ectopic pregnancy. Variations, like
single nucleotide polymorphisms (SNPs), in immunologically important host genes are assumed to play a
role in the course and outcome of a C. trachomatis infection. We studied whether genetic traits (carrying
multiple SNPs in different genes) in the bacterial sensing system are associated with an aberrant immune
response and subsequently with tubal pathology following a C. trachomatis infection. The genes studied all
encode for pattern recognition receptors (PRRs) involved in sensing bacterial components.
Methods: Of 227 subfertile women, serum was available for C. trachomatis IgG antibody testing and
genotyping (common versus rare allele) of the PRR genes TLR9, TLR4, CD14 and CARD15/NOD2. In all
women, a laparoscopy was performed to assess the grade of tubal pathology. Tubal pathology was defined
as extensive peri-adnexal adhesions and/or distal occlusion of at least one tube.
Results: Following a C. trachomatis infection (i.e. C. trachomatis IgG positive), subfertile women carrying
two or more SNPs in C. trachomatis PRR genes were at increased risk of tubal pathology compared to
women carrying less than two SNPs (73% vs 33% risk). The differences were not statistically significant (P
= 0.15), but a trend was observed.
Conclusion: Carrying multiple SNPs in C. trachomatis PRR genes tends to result in an aberrant immune
response and a higher risk of tubal pathology following a C. trachomatis infection. Larger studies are needed
to confirm our preliminary findings.
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Background
A large variation exists in the individual response to a
Chlamydia (C.) trachomatis infection. Some women clear a
C. trachomatis infection adequately without developing
tissue damage, whereas others get a persistent infection
which may ascend to the upper genital tract, increasing
the risk of tubal damage and subfertility. The susceptibil-
ity, course and outcome of infectious diseases are deter-
mined by environmental factors, virulence factors of the
pathogen and host factors.
Immunogenetic studies evaluate the role of genetic varia-
tions in immunologically important host genes as deter-
minants of the susceptibility, course and outcome of
infectious diseases. Among these variations are single
nucleotide polymorphisms (SNPs), in which one nucle-
otide has been substituted, inserted or deleted. This may
lead to synthesis of a potentially aberrant protein, or to
up- or downregulation of the normal protein, and subse-
quently to an aberrant immune response, increasing the
risk of late sequelae of infectious diseases (e.g. tubal
pathology following a C. trachomatis infection).
In the present study, we have evaluated SNPs in genes
encoding for pattern recognition receptors (PRRs). PRRs
are present on or in circulating cells of the innate immune
system (e.g. macrophages) and local cells (e.g. epithelial
cells of the upper genital tract). PRRs are involved in the
bacterial sensing pathways of the innate immune system
by recognizing the so-called pathogen-associated molecu-
lar patterns (PAMPs), which are pathogen-specific cell
wall components or intracellular components. Since dif-
ferent PRRs recognize different PAMPs, pathogen recogni-
tion and initiation of the immune response is a complex
and flexible system.
Carrying a SNP in a single PRR may not result in a large
effect on disease severity, since other PRRs may compen-
sate for the partial loss of function in a specific pathogen
recognition route. Subsequently, SNPs in only one PRR
may not play a significant role as risk factors for the devel-
opment of C. trachomatis-associated tubal pathology, as
shown for the PRR toll-like receptor (TLR) 4 [1] and its co-
receptor cluster of differentiation (CD) 14 [2]. However,
carrying multiple SNPs in one gene or in multiple genes
(in so-called carrier traits) may be associated with an
increased risk of tubal pathology. Smirnova et al. (2003)
[3] have found that combinations of TLR4 variants are
markedly more common in patients with meningococcal
infections, whereas single variants are not over-repre-
sented in those patients. In studies on gastrointestinal
malignancies, it has been concluded that carrying multi-
ple pro-inflammatory polymorphisms is associated with
an increased risk of gastric cancer [4,5]. Furthermore,
studies on the relationship between caspase recruitment
domain (CARD) 15/nucleotide oligomerisation domain
(NOD) 2 genetic variants, of which SNP8, SNP12 and
SNP13 are most studied, and Crohn's disease have shown
that compound heterozygous subjects (carriers of two dif-
ferent genetic variants, e.g. SNP12 genotype 1.2 and
SNP13 genotype 1.2) have a higher risk of Crohn's disease
as compared to homozygous subjects (carriers of the same
genetic variant on both chromosomes, e.g. SNP12 geno-
type 2.2) [6,7].
Analogous to these findings, we hypothesized that carry-
ing multiple genetic variations in multiple PRRs (in a so-
called carrier trait) may increase the risk of C. trachomatis-
associated tubal pathology in subfertile women. Accord-
ing to their biological function (recognition of C. trachom-
atis PAMPs: see Table 1), four PRRs were selected: TLR9,
TLR4, CD14 and CARD15/NOD2. Five relatively com-
mon SNPs, which are assumed to influence the receptor
function, in these four PRR genes were studied in this car-
rier trait analysis (see Table 1).
Methods
Study population
The study was performed in women who visited the Aca-
demic Hospital Maastricht between December 1990 and
November 2000 because of subfertility. In all patients
blood was drawn at their initial visit for a Chlamydia IgG
antibody test (CAT). All spare sera were cryopreserved.
Only patients who had undergone a laparoscopy and
tubal testing as part of their fertility work-up were
included in the present study. Since the prevalence of
Table 1: The pattern recognition receptors (PRRs), which recognize C. trachomatis pathogen-associated molecular patterns (PAMPs), 
and the single nucleotide polymorphisms (SNPs) studied
PRR PAMP SNP
TLR9 CpG-rich motifs -1237 T>C and +2848 G>A
TLR4 LPS and HSP +896 A>G
CD14 LPS and HSP (co-receptor of TLR4) -260 C>T
CARD15/NOD2 Peptidoglycans Leu1007fsinsC (SNP13)
TLR = toll-like receptor; CD = cluster of differentiation; CARD = caspase recruitment domain; NOD = nucleotide oligomerisation domain; CpG = 
cytosine-phosphate-guanine; LPS = lipopolysaccharide; HSP = heat shock protein; T = thymine; C = cytosine; G = guanine; A = adenine; Leu = 
leucine-rich repeat domain; fsins = frameshift insertion.BMC Infectious Diseases 2006, 6:122 http://www.biomedcentral.com/1471-2334/6/122
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SNPs may depend on ethnical background, only Dutch
Caucasian women were included. Patients who had
undergone previous pelvic surgery (except for an unevent-
ful appendectomy or Caesarean section) were excluded.
In the Netherlands, for retrospective analysis of ano-
nymized patient data and stored sera no ethical commit-
tee approval is required. In the fertility clinic of the
Academic Hospital Maastricht, all couples are informed at
intake about possible use of their anonymized data and
stored sera for research purposes, and a "no objection pro-
cedure" is followed. Only patients having not objected
participated in the present study.
Two independent investigators, who were unaware of the
CAT results, scored 259 successive laparoscopy reports to
assess the grade of tubal pathology. Tubal pathology was
defined as extensive peri-adnexal adhesions and/or distal
occlusion of at least one tube [8]. In case of disagreement,
consensus was reached by consultation.
Of the 259 women who underwent a laparoscopy, 43
(17%) had tubal pathology (according to the above-men-
tioned definition) and 184 (71%) had no tubal pathology
(no peri-adnexal adhesions and patent tubes), and these
227 women participated in the present study. Thirty-two
women (12%) had minor or non-C. trachomatis-related
abnormalities (any peri-adnexal adhesions and/or proxi-
mal occlusion of at least one tube) and were excluded.
C. trachomatis IgG antibody testing
IgG antibodies to C. trachomatis were detected using the
species-specific Chlamydia pneumoniae IgG micro-immun-
ofluorescence (MIF) test (AniLabsystems, Finland), as
described previously [9]. This species-specific test is able
to detect IgG antibodies to both C. pneumoniae and C. tra-
chomatis (using an antigen derived from a C. trachomatis
LGV strain, serovar L2). We have previously studied the
test performances of five commercially available C. tracho-
matis IgG tests, including the C. trachomatis IgG spot in the
C. pneumoniae MIF (AniLabsystems) [10]. In our hands,
the C. trachomatis IgG titre obtained by the C. pneumoniae
MIF (AniLabsystems) had the best predictive value for
tubal factor subfertility [10]. Therefore, we have used this
test in the present study. The cut-off titre used for a posi-
tive test was 32.
Immunogenetic analysis
For the immunogenetic analyses, genomic DNA was
extracted from the cryopreserved serum samples using
either the MagNaPure LC isolator according to the manu-
facturers' instructions (Roche Molecular Biochemicals,
Germany) or the High Pure PCR Template Preparation
(HPPTP) Kit according to the manufacturers' instructions
(Roche Molecular Biochemicals, Germany). Both tech-
niques provide enough DNA for reproducible genetic
analyses. Genotyping was performed using a polymerase
chain reaction (PCR)-based restriction fragment length
polymorphism (RFLP)-assay or TaqMan-assay as
described previously [2,11-13]. The SNPs studied are sum-
marized in Table 1. Chromosomal locations and further
information on the genes studied are: TLR9 chromosomal
location 3p21.3, TLR9 -1237 T>C rs5743836 and TLR9
+2848 G>A rs352140; TLR4 chromosomal location 9q32-
q33, TLR4 +896 A>G rs4986790; CD14 chromosomal
location 5q31.1, CD14 -260 C>T rs25691909; CARD15/
NOD2 chromosomal location 16q21, CARD15/NOD2
Leu1007fsinsC (SNP13) rs2066847. For ethnically-
matched background genotyping, genomic DNA was
extracted from whole blood of 97 healthy Dutch Cauca-
sian employees of the VU University Medical Center. They
gave written informed consent for use of their ano-
nymized sera to serve as control sera for genetic research
purposes.
Statistical methods
The genotype distribution was tested for Hardy-Weinberg
equilibrium to assess Mendelian inheritance. Fisher's
exact or χ2 tests were used to compare the single genotypes
between C. trachomatis IgG-positive and IgG-negative sub-
fertile women with and without tubal pathology and the
healthy control group. Subsequently, the single genotypes
were used to define carrier traits. The carrier traits were
tested in χ2 and trend analyses. P < 0.05 was considered
statistically significant.
Results
Of all 227 subfertile women participating in the present
study, 43 (19%) had tubal pathology, whereas 184 (81%)
did not have tubal pathology. C. trachomatis IgG antibod-
ies were present in 39 women, of whom 26 (67%) had
tubal pathology and 13 (33%) did not have tubal pathol-
ogy.  C. trachomatis IgG antibodies were absent in 188
women, of whom 17 (9%) had tubal pathology and 171
(91%) did not have tubal pathology.
For all genes studied, the genotype distribution was in
Hardy-Weinberg equilibrium in the subfertile women and
the ethnically-matched control group.
The genotype distribution did not differ between subfer-
tile women, the C. trachomatis IgG-positive subgroup of
subfertile women and the healthy control group (Table
2), indicating that the subfertile women participating in
the study reflect an average Dutch Caucasian population
regarding the genotype distribution.
Single gene analysis
The risk of tubal pathology was assessed in all subfertile
women and in the C. trachomatis IgG-positive subgroup in
relation to the genotype of TLR9, TLR4, CD14 andBMC Infectious Diseases 2006, 6:122 http://www.biomedcentral.com/1471-2334/6/122
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CARD15/NOD2 (Table 2; Figure 1). An increasing risk of
tubal pathology was observed across the genotypes in all
genes except CD14. Carrying SNPs in these genes
increased the risk of tubal pathology (on average almost
20%). These differences did not reach statistical signifi-
cance. These single genotypes were used to define carrier
traits.
Carrier trait analysis
The SNPs in the single genes were combined in carrier
traits. The risk of tubal pathology was assessed in C. tra-
chomatis IgG-positive and IgG-negative subfertile women
in relation to the number of SNPs. Carrying two or more
SNPs did not influence the risk of tubal pathology in C.
trachomatis IgG-negative women as compared to C. tracho-
matis IgG-negative women carrying less than two SNPs
(9% vs. 8% risk respectively; Figure 2). However, carrying
multiple SNPs doubled the risk of tubal pathology in C.
trachomatis IgG-positive women as compared to C. tracho-
matis IgG-positive women with less than two SNPs (73%
vs. 33% risk respectively; Figure 2). These differences did
not reach statistical significance (P  = 0.15) but a clear
trend was observed.
Discussion
Over the last decade, immunogenetic studies have pro-
vided insight in the pathogenesis of and susceptibility to
infectious diseases. So far, the role of SNPs in immunolog-
ically relevant genes has been established in numerous
diseases, e.g. sexually transmitted infections [14-16] and
inflammatory bowel diseases (Crohn's disease and ulcer-
ative colitis) [17,18]. In this study, we analyzed the role of
single SNPs and multiple SNPs in multiple genes (in a so-
called carrier trait) as risk factors of C. trachomatis-related
tubal pathology and we confirmed our hypothesis that a
carrier trait based on genes in bacterial sensing pathways
had a stronger association with the risk of tubal pathology
than a single gene analysis.
Recent studies have shown the value of genetic traits in
complex diseases. Carrying multiple SNPs in the same
gene, or multiple SNPs in multiple genes, has been asso-
ciated with an increased risk of infectious diseases and
malignancies [3,4,6,7]. Analogous to these findings, we
hypothesized that the disregulation of the immune
response by the presence of multiple SNPs may lead to an
even higher risk of tubal pathology following a C. tracho-
matis infection as compared to carrying a single SNP.
In this study, we investigated the role of five SNPs in four
genes which are assumed to play a role in the recognition
of C. trachomatis (see Table 1). An adequate recognition of
C. trachomatis by PRRs is the first step in the immune
response. Recent studies have shown that TLR1-9 are
expressed in the human female genital tract. TLR4 and its
co-receptor CD14 are predominantly expressed in the fal-
Table 2: The risk of tubal pathology (TP) in relation to the genotype of the single genes studied.
1.1 1.2 and 2.2
n Risk of TP n Risk of TP
TLR9 -1237 T>C All subfertile women 155 (68%) 20% 72 (32%) 17%
CT+ subfertile women 26 (67%) 62% 13 (33%) 77%
Control group 66 (68%) - 31 (32%) -
TLR9 +2848 G>A All subfertile women 45 (20%) 18% 182 (80%) 19%
CT+ subfertile women 6 (15%) 50% 33 (85%) 70%
Control group 15 (15%) - 82 (85%) -
TLR4 +896 A>Ga All subfertile women 200 (88%) 19% 27 (12%) 22%
CT+ subfertile women 33 (85%) 64% 6 (15%) 83%
Control group 87 (90%) - 10 (10%) -
CD14 -260 C>Tb All subfertile women 60 (26%) 17% 167 (74%) 20%
CT+ subfertile women 12 (31%) 67% 27 (69%) 67%
Control group 26 (27%) - 71 (73%) -
CARD15/NOD2 All subfertile women 211 (93%) 18% 16 (7%) 25%
Leu1007fsinsC CT+ subfertile women 37 (95%) 65% 2 (5%) 100%
(SNP13) Control group 95 (98%) - 2 (2%) -
All subfertile women: n = 227, of whom 19% has tubal pathology (TP).
CT + (C. trachomatis IgG-positive) subfertile women: n = 39, of whom 67% has TP.
Control group: n = 97 ethnically-matched healthy employees of the VU University Medical Center.
1.1 = normal genotype (homozygous for the common allele); 1.2 = heterozygous SNP carrier (one common allele and one rare allele); 2.2 = 
homozygous SNP carrier (homozygous for the rare allele).
a Adapted from Morré et al., 2003 [1].
b Adapted from Ouburg et al., 2005 [2].BMC Infectious Diseases 2006, 6:122 http://www.biomedcentral.com/1471-2334/6/122
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lopian tubes, where they may play an important role in
the innate host defence mechanism against ascending C.
trachomatis  infections [19-21]. Regarding CARD15/
NOD2, it is not clear whether it plays a role in the C. tra-
chomatis recognition in the genital tract, although NOD
proteins have been shown to be involved in the intracel-
lular sensing of C. pneumoniae in endothelial cells [22].
Our data show a doubling of the risk of tubal pathology
in  C. trachomatis IgG-positive women carrying two or
more SNPs as compared to C. trachomatis IgG-positive
women carrying less than two SNPs (73% vs. 33% risk).
The differences did not reach statistical significance (P =
0.15) due to the small sample size (227 subfertile women
in total, including 39 C. trachomatis IgG-positive subfertile
women, of whom 67% has tubal pathology). If the asso-
ciation found in this pilot study would be confirmed in a
larger cohort, a 50% increase in sample size (to 341 sub-
fertile women) would result in a significant difference (P
= 0.047) between C. trachomatis IgG-positive subfertile
The risk of tubal pathology (TP) in C. trachomatis IgG-positive (CT+) and IgG-negative (CT-) subfertile women in relation to  carrying five single nucleotide polymorphisms (SNPs) in four pattern recognition receptor genes Figure 2
The risk of tubal pathology (TP) in C. trachomatis IgG-positive (CT+) and IgG-negative (CT-) subfertile women in relation to 
carrying five single nucleotide polymorphisms (SNPs) in four pattern recognition receptor genes.
The risk of tubal pathology (TP) in C. trachomatis IgG-positive subfertile women in relation to the genotype of the single pattern  recognition receptor genes Figure 1
The risk of tubal pathology (TP) in C. trachomatis IgG-positive subfertile women in relation to the genotype of the single pattern 
recognition receptor genes. a Adapted from Morré et al., 2003 [1]. b Adapted from Ouburg et al., 2005 [2].BMC Infectious Diseases 2006, 6:122 http://www.biomedcentral.com/1471-2334/6/122
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women carrying two or more SNPs versus C. trachomatis
IgG-positive subfertile women carrying less than two
SNPs regarding the risk of tubal pathology. A 100%
increase in sample size (to 454 subfertile women) would
result in a strong association (P = 0.016; OR: 5.3) between
carrying two or more SNPs and an increased risk of tubal
pathology. Increasing the sample size twofold would not
be possible however in our setting in a reasonable time
frame. Although the present study was performed in a
large fertility clinic and patients were included during a
ten-year period, the number of affected women remained
small, due to the low prevalence of IgG-positivity in com-
bination with both carrying multiple SNPs and tubal
pathology.
From our results it can be concluded that an adequate rec-
ognition of the pathogen at the site of infection seems to
be a relevant step in the immune response, and that carry-
ing multiple SNPs in multiple C. trachomatis PRR genes
tends to increase the risk of an aberrant immune response
and tubal pathology. To draw significant conclusions, our
hypothesis should be retested in further studies using a
larger cohort.
As expected, a difference in risk of tubal pathology
between C. trachomatis IgG-positive women and C. tracho-
matis  IgG-negative women was observed. In previous
studies, the presence of C. trachomatis IgG antibodies, an
indicator of a previous C. trachomatis infection, has been
associated with tubal pathology [23]. Our data show that
carrying multiple SNPs in bacterial sensing pathways and
a previous C. trachomatis infection synergistically enhance
the risk of tubal pathology, while carrying these SNPs does
not influence the risk of tubal pathology in the absence of
a previous C. trachomatis infection (Figure 2).
Conclusion
We hypothesized that carrier traits (i.e. carrying multiple
SNPs in multiple genes) that likely result in an aberrant
immune response are associated with tubal pathology fol-
lowing a C. trachomatis infection. In 227 subfertile
women, we studied five variations in four genes encoding
for pattern recognition receptors, which recognize several
pathogen-associated molecular patterns of C. trachomatis.
The presence of two or more SNPs tends to correlate with
an increased risk of tubal pathology following a C. tracho-
matis infection as compared to a lower number of SNPs.
Further studies in a larger cohort are needed to confirm
our preliminary findings. An adequate recognition of C.
trachomatis by receptors in the genital tract seems to be a
relevant step in the immune response, and may play a role
in protecting the host against the development of late
sequelae following a C. trachomatis infection.
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